Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market By End User (Pharma Customers, Biotech Customers, Others); By Product (Active Pharmaceutical Ingredients, Finished Drugs); By Type of Fermentation (Aerobic, Anaerobic); By Dosage Forms (Immediate Release and Controlled Release Tablets, Multilayer Tablets, Immediate Release Capsules, Oral Multiparticulates like Beads, Pellets and Mini-tablets, Liquid and Semi-solid Filled Capsules, Fast Dispersible Tablets, Coating of Tablets, Capsules and Pellets, Micro-encapsulation Using Spray Drying, Oral Liquids and Suspensions, Liquids and Semi-solids for Topical Delivery like Creams, Ointments, Lotions and Gels, Buccal Delivery, Nasal Sprays, Dental Products, Pessaries, Others); By Clinical Phases (Phases I Trials, Phase II/ III Trials, Others); By Disease Indication (Gastrointestinal Disorders and Food Allergies – Ulcerative Colitis, Irritable Bowel Syndrome, Others, Cardiovascular Diseases, Metabolic, Autoimmune and Neurological Disorders, Diabetes, Cancer – Colon Cancer, Others, Infectious Diseases, Others); By Services (Cell Bank Preservation, Inoculum/ Seed Optimization, Media Optimization, Formulation, Fermentation Development, Harvest Development, Lyophilization Development, Analytical Method Development, Process Scale-up, Liquid Filling Services, Custom Packaging Services, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
